JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141005

BQ-123, ETA receptor antagonist

Be the first to review this product! Submit a review

|

(4 Publications)

MW 610.7 Da, Purity >95%. Achieve your results faster with highly validated, pure and trusted compounds.
1 Images
Chemical Structure - BQ-123, ETA receptor antagonist (AB141005)
  • Chemical Structure

Lab

Chemical Structure - BQ-123, ETA receptor antagonist (AB141005)

2D chemical structure image of ab141005, BQ-123, ETA receptor antagonist

Key facts

CAS number

136553-81-6

Purity

>95%

Form

Solid

form

Molecular weight

610.7 Da

Molecular formula

C<sub>3</sub><sub>1</sub>H<sub>4</sub><sub>2</sub>N<sub>6</sub>O<sub>7</sub>

PubChem

443289

Nature

Synthetic

Solubility

Soluble in water to 1.25 mg/ml

Biochemical name

Cyclo(D-trp-D-asp-pro-D-val-leu)

Canonical smiles

CC(C)CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43

Isomeric smiles

CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43

InChi

InChI=1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23+,24-,26+/m0/s1

InChiKey

VYCMAAOURFJIHD-PJNXIOHISA-N

IUPAC Name

2-[(3R,6R,9S,12R,15S)-6-(1H-indol-3-ylmethyl)-9-(2-methylpropyl)-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-3-yl]acetic acid

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Disease models & mechanisms 14: PubMed34664634

2021

Early manifestations and differential gene expression associated with photoreceptor degeneration in Prom1-deficient retina.

Applications

Unspecified application

Species

Unspecified reactive species

Yuka Kobayashi,Shizuka Watanabe,Agnes Lee Chen Ong,Manabu Shirai,Chiemi Yamashiro,Tadahiko Ogata,Fumiaki Higashijima,Takuya Yoshimoto,Takahide Hayano,Yoshiyuki Asai,Noriaki Sasai,Kazuhiro Kimura

BMC cancer 20:751 PubMed32787791

2020

Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Zaid H Maayah,Shingo Takahara,Abrar S Alam,Mourad Ferdaoussi,Gopinath Sutendra,Ayman O S El-Kadi,John R Mackey,Edith Pituskin,D Ian Paterson,Jason R B Dyck

Brain research 1701:196-203 PubMed30244111

2018

CT perfusion imaging of cerebral microcirculatory changes following subarachnoid hemorrhage in rabbits: Specific role of endothelin-1 receptor antagonist.

Applications

Unspecified application

Species

Unspecified reactive species

Quanyang Wu,Ruibin Zheng,Jiao Wang,Jiaqi Wang,Songbai Li

Anesthesiology 128:1207-1219 PubMed29461271

2018

Endothelin Signaling Contributes to Modulation of Nociception in Early-stage Tongue Cancer in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Akihiko Furukawa,Masamichi Shinoda,Asako Kubo,Kuniya Honda,Ryuta Akasaka,Yoshiyuki Yonehara,Koichi Iwata
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com